Cesar G. Baiocchi

Rua Treze De Maio 1815, 1º Subsolo Bloco B, Bela Vista
Sao Paulo, SP 01323020, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis.

Three-year cardiovascular and non-cardiovascular adverse events in patients with chronic lymphocytic leukemia or small cell lymphocytic lymphoma treated with Bruton tyrosine kinase inhibitors acalabrutinib or ibrutinib: a real-world analysis.

Journal: Annals of hematology

Published: April 27, 2024

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability.

Current perspectives on the management of refractory or relapsed classic hodgkin lymphoma in brazil: Balancing efficacy, safety, and tolerability.

Journal: Oncotarget

Published: December 12, 2023

Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?

Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?

Journal: Frontiers in oncology

Published: February 27, 2023

Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients.

Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients.

Journal: Annals of hematology

Published: June 05, 2022

Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report.

Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report.

Journal: Blood research

Published: July 27, 2020

How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.

How to manage lymphoid malignancies during novel 2019 coronavirus (CoVid-19) outbreak: a Brazilian task force recommendation.

Journal: Hematology, transfusion and cell therapy

Published: March 27, 2020

Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.

Lenalidomide in the management of eosinophilic dermatosis of hematological malignancy.

Journal: The Journal of dermatology

Published: August 02, 2018

Quality Oncology Practice Initiative Can Guide and Improve Oncology Providers' Training in Brazil.

Quality Oncology Practice Initiative Can Guide and Improve Oncology Providers' Training in Brazil.

Journal: Journal of global oncology

Published: July 19, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026